Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 11/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | MC5R | P33032 | 6/20 | 0.39 |
| ▸ | MC3R | P41968 | 6/20 | 0.39 |
| ▸ | MC1R | Q01726 | 6/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | TACR1 | P25103 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5411342 | 0.81 | MC4R (0.49) | MC4RCNR2MC5RMC3RMC1R | |
| SCHEMBL5418108 | 0.79 | MC4R (0.46) | MC4RCNR2MC5RMC3RMC1R | |
| SCHEMBL5413876 | 0.78 | MC4R (0.49) | MC4RCNR2MC5RMC3RMC1R | |
| SCHEMBL5403197 | 0.78 | MC4R (0.54) | MC4RMC5RMC3RMC1R | |
| SCHEMBL5410833 | 0.76 | MC4R (0.49) | MC4RCNR2MC5RMC3RMC1R | |
| SCHEMBL14593419 | 0.74 | MC4R (0.58) | MC4RMC5RMC3RMC1R | |
| SCHEMBL5407926 | 0.74 | MC4R (0.58) | MC4RMC5RMC3RMC1R | |
| SCHEMBL6156123 | 0.72 | KDM4E (0.48) | LMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL5411151 | 0.71 | MC4R (0.45) | MC4RMC5RMC3RMC1R | |
| SCHEMBL5411345 | 0.71 | MC4R (0.48) | MC4RMC5RMC3RMC1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7169777-B2 | Melanocortin receptor agonists | ELI LILLY AND COMPANY (US) | 2007-01-30 | — | — | US | claimed |
| US-20040116699-A1 | Melanocortin receptor agonists | ELI LILLY AND COMPANY | 2004-06-17 | — | — | US | claimed |
| EP-1358163-A1 | MELANOCORTIN RECEPTOR AGONISTS | ELI LILLY AND COMPANY (US) | 2003-11-05 | — | — | EP | claimed |
| WO-2002059095-A1 | MELANOCORTIN RECEPTOR AGONISTS | ELI LILLY AND COMPANY (US) | 2002-08-01 | — | — | WO | claimed |
| US-7169777-B2 | Melanocortin receptor agonists | ELI LILLY AND COMPANY (US) | 2007-01-30 | — | — | US | disclosed |
| US-20040116699-A1 | Melanocortin receptor agonists | ELI LILLY AND COMPANY | 2004-06-17 | — | — | US | disclosed |
| EP-1358163-A1 | MELANOCORTIN RECEPTOR AGONISTS | ELI LILLY AND COMPANY (US) | 2003-11-05 | — | — | EP | disclosed |
| WO-2002059095-A1 | MELANOCORTIN RECEPTOR AGONISTS | ELI LILLY AND COMPANY (US) | 2002-08-01 | — | — | WO | disclosed |